Akovaz Side Effects
Generic name: ephedrine
Medically reviewed by Drugs.com. Last updated on May 5, 2023.
Note: This document contains side effect information about ephedrine. Some dosage forms listed on this page may not apply to the brand name Akovaz.
Applies to ephedrine: oral fixed-dose combination with guaifenesin, parenteral injection.
Side effects include:
Parenteral ephedrine (the active ingredient contained in Akovaz) Nervousness, insomnia, vertigo, headache, tachycardia, palpitation, sweating, nausea, vomiting, anorexia, vesical sphincter spasm (resulting in difficult and painful urination), urinary retention (particularly in males with prostatism).
For Healthcare Professionals
Applies to ephedrine: compounding powder, injectable solution, intravenous solution, oral capsule, oral tablet.
General
The most frequently reported side effects were nausea, vomiting, and tachycardia.[Ref]
Cardiovascular
Very rare (less than 0.01%): Myocardial infarction
Frequency not reported: Tachycardia, palpitations, reactive hypertension, bradycardia, ventricular ectopics, R-R variability, pallor, angina/anginal pain, hypertension, hypotension, extrasystole, arrhythmias, vasodilation with low blood pressure, flushing, impaired circulation to extremities[Ref]
Genitourinary
Frequency not reported: Difficult/painful urination, acute urinary retention[Ref]
Nervous system
Frequency not reported: Dizziness, headache, trembling, lightheadedness, tremor, sedation[Ref]
Respiratory
Frequency not reported: Dry nose, dry throat, shortness of breath, respiratory difficulty, dyspnea, respiratory depression[Ref]
Psychiatric
Frequency not reported: Restlessness, addiction, nervousness, anxiety, insomnia, mood/mental changes, fear, irritability, confusion, delirium, euphoria, psychotic states, tension, hallucinations[Ref]
Other
Frequency not reported: Fever, precordial pain, vertigo, tachyphylaxis, drug tolerance, drug dependence, weakness[Ref]
Gastrointestinal
Frequency not reported: Nausea, vomiting, dry mouth, mild epigastric distress, hypersalivation[Ref]
Metabolic
Frequency not reported: Hyperglycemia, anorexia[Ref]
Dermatologic
Frequency not reported: Sweating[Ref]
More about Akovaz (ephedrine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: decongestants
Patient resources
Other brands
Professional resources
Related treatment guides
References
1. Product Information. EPHEDrine Sulfate (ePHEDrine). Akorn Inc. 2022.
2. Cerner Multum, Inc. UK Summary of Product Characteristics.
3. Cerner Multum, Inc. Australian Product Information.
4. Product Information. Akovaz (ephedrine). Eclat Pharmaceuticals. 2016.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.